Evidation Health

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Evidation Health sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

Evidation Health: 12 sponsored US clinical trials, none currently recruiting.

Evidation Health sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. The most-studied condition in this pipeline is Influenza a, with 2 trials.

Top-decile sponsor footprint

Evidation Health ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED NA

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

NCT06229444
COMPLETED

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

NCT06207929
COMPLETED

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

NCT04623138
COMPLETED NA

A Digital Flu Intervention for People With Cardiovascular Conditions

NCT04584645
COMPLETED

Home Testing of Respiratory Illness

NCT04245800
COMPLETED NA

Influenza Vaccination Digital Interventions for People Living With Diabetes

NCT03870997
COMPLETED

Digital Signals in Chronic Pain (DiSCover Project)

NCT03421223
COMPLETED NA

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

NCT03363100
COMPLETED NA

Asthma Control Study

NCT03304067
COMPLETED NA

Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

NCT03092882
COMPLETED NA

Neurotrack Virtual Cognitive Health Study

NCT02969460
COMPLETED NA

One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c

NCT02827669

Therapeutic Areas

Influenza a 2
Influenza Type B 1
Influenza B 1
Respiratory Syncytial Virus (RSV) 1
Respiratory Viral Infection 1
Influenza-like Illness 1
Influenza, Human 1
Respiratory Tract Infections 1
Diabetes Mellitus, Type 2 1
COVID-19 1

How the Evidation Health archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Influenza a (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Evidation Health: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Evidation Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Evidation HealthAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
Evidation Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Evidation Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Evidation Health page

12 registered trials is a research-attention snapshot, not an endorsement of Evidation Health or any single study.

  • None of Evidation Health's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Influenza a is the condition Evidation Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Influenza a trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Evidation Health pipeline card: 12 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.